Healthcare 16 February 2026 - 2 March 2026

Business News·Healthcare·Legal Issues·NASDAQ:ACHC·News

Acadia Healthcare Rises Even as New Legal Issue Emerges

Acadia Healthcare Company shares climbed Tuesday, beating gains in the major U.S. indexes, as buyers stuck with the behavioral-health hospital operator’s shaky turnaround story. The stock ended Nasdaq trading at $24.42, gaining $1.11, or 4.76%. About 2.32 million shares changed hands, roughly matching recent volume. Shares are still below the 52-week high of $30.20.

June 3, 2026

Finance·Healthcare·News·Stock Market

UnitedHealth (UNH) stock price holds near $294 as Medicare regulator targets rival Elevance

New York, March 2, 2026, 15:46 — Regular session UnitedHealth Group Incorporated traded mostly flat Monday, with shares inching up roughly 0.2% to $293.71 as the latest round of Medicare regulation risk in managed care kept investors on alert.

March 2, 2026

Finance·Healthcare·Investing·News

Eli Lilly stock price closes at $1,051.99 — EU nod lifts focus ahead of Monday’s CFO talk

New York, March 1, 2026, 11:19 EST — Market has shut for the day. Eli Lilly and Co closed out Friday with a 2.9% gain to $1,051.99, bucking the broader market’s weakness as traders digested a fresh regulatory move in Europe tied to the company’s immunology lineup.

March 1, 2026

Finance·Healthcare·News·Stock Market

Merck (MRK) stock price jumps after Keytruda survival data; Gardasil layoffs in focus next week

New York, Feb 27, 2026, 19:17 EST — After-hours Merck & Co finished Friday up roughly 3.8%, settling at $123.82. After the bell, shares barely budged. The uptick followed reports linking the gain to new clinical data on its flagship cancer treatment, Keytruda.

February 28, 2026

Finance·Healthcare·News·Stock Market

UnitedHealth stock price drops as Medicare Advantage enrollment slips; UNH investors eye CMS rates

New York, Feb 26, 2026, 12:03 EST — Regular session UnitedHealth Group dropped $7.58, or roughly 2.6%, to settle at $284.20 on Thursday. The stock moved in a band from $281.50 to $291.70 during the session.

February 26, 2026

Finance·Healthcare·News·Stock Market

Sigma Healthcare share price whipsaws after 1H26 results — dividend dates and GLP-1 boost in focus

Sydney, Feb 26, 2026, 17:55 AEDT — The market has closed. Sigma Healthcare Ltd dropped 1.7% to A$2.94 by Thursday’s close, giving up earlier gains. Shares kicked off at A$3.15, peaked at A$3.20, then reversed lower into the final bell.

February 26, 2026

CSE:NOVOB.CO·Finance·Healthcare·News·Stock Market

Novo Nordisk stock slips again as Wegovy price cuts and CagriSema doubts weigh

Copenhagen, Feb 25, 2026, 13:46 CET — Regular session Novo Nordisk slipped roughly 1.7% to 239.5 Danish crowns on Wednesday. The shares continued to feel pressure after new U.S. pricing steps and lingering doubts about its upcoming obesity drug.

February 25, 2026

Finance·Healthcare·News·NYSE:UNH·Stock Market

UnitedHealth stock extends slide after bell as Medicare Advantage deadline nears

New York, Feb 24, 2026, 18:00 EST — After-hours UnitedHealth Group Incorporated dropped 2.6% to $273.95 in Tuesday’s after-hours session, deepening a two-day pullback that’s weighed on the Dow component, even as the wider market managed a rebound.

February 25, 2026

Finance·Healthcare·News·Stock Market

JNJ stock price today: Johnson & Johnson shares hold steady as drug news and a Bayer lawsuit collide

New York, Feb 24, 2026, 15:02 — Regular session Johnson & Johnson stock hovered near flat in the afternoon, edging lower by 0.1% to $245.6 as traders weighed a batch of drug news and court updates. Shares moved in a tight band, between about $244.6 and $247.3, after picking up 1.4% the previous session. The S&P 500, meanwhile, showed more strength, up around 0.8%.

February 24, 2026

Finance·Healthcare·News·Stock Market

Pro Medicus (ASX:PME) tumbles again — what to know before the next session

Sydney, Feb 23, 2026, 18:24 AEDT — The market is shut for the day. Pro Medicus dropped 8.9% to A$115.30 on Monday, with the radiology software company's slide extending, sending shares closer to their recent lows.

February 23, 2026

Healthcare·News·NYSE:ABBV·Pharmaceuticals·Stock Market

AbbVie stock (ABBV): FDA clears new Venclexta-Calquence CLL combo — what to watch Monday

New York, Feb 22, 2026, 15:09 EST — Market closed AbbVie heads into the new week after U.S. regulators approved a new first-line combination for chronic lymphocytic leukemia, pairing AstraZeneca’s Calquence with AbbVie’s Venclexta. The FDA said the regimen improved progression-free survival — the time before the disease worsens — versus standard chemoimmunotherapy in the AMPLIFY study.

February 22, 2026

Finance·Healthcare·News·Pharmaceuticals

Eli Lilly stock drops into weekend as GLP-1 copycat crackdown tightens — what to watch next

New York, Feb 21, 2026, 13:15 EST — The market is closed. Eli Lilly and Co closed out Friday at $1,009.52, slipping 1.34%.

February 21, 2026

Finance·Healthcare·Investing·News

Johnson & Johnson stock slips as $20 billion DePuy sale talk grows — what investors watch next

New York, Feb 20, 2026, 11:25 EST — Regular session Johnson & Johnson shares slipped 2.1% to $241.75 Friday morning, following a Reuters report that the healthcare giant is gearing up to sell its DePuy Synthes orthopedics business in a deal that could top $20 billion. DePuy Synthes generated $9.3 billion in sales in 2025, with products ranging from hip and knee implants to surgical tools and other devices.

February 20, 2026

Finance·Healthcare·Investment·News·NYSE:CVS·NYSE:ELV·NYSE:HUM·NYSE:UNH

UnitedHealth stock edges up near $290 as Medicare Advantage shakeout returns to spotlight

New York, Feb 19, 2026, 15:32 — Regular session UnitedHealth Group Incorporated traded at $289.57, up 0.5% Thursday afternoon. The stock shifted between $286.90 and $290.48 during the session, with roughly 3.1 million shares traded.

February 19, 2026

Finance·Healthcare·News·Stock Market

UnitedHealth stock slips as Medicare Advantage plan disruptions hit headlines — what to watch before April 6

New York, Feb 18, 2026, 15:00 EST — Regular session UnitedHealth Group slipped Wednesday, off roughly 0.1% at $288.83 as of mid-afternoon New York time.

February 18, 2026

Finance·Healthcare·News·NYSE:LLY·Stock Market

Eli Lilly stock slips even after Zepbound-Taltz psoriasis data; investors eye what’s next for LLY

New York, Feb 18, 2026, 11:32 EST — Regular session Eli Lilly and Company slipped roughly 1.8% Wednesday, despite unveiling new late-stage results for its Zepbound-Taltz combo. By 11:32 a.m. EST, shares were off $18.19 at $1,017.86. The S&P 500 was up about 0.8% at that point, though healthcare names lagged, ticking down.

February 18, 2026

Finance·Healthcare·Investing·News

AbbVie stock rises as ABBV investors brace for Feb 20 inflation read and Botox pricing fight

New York, Feb 17, 2026, 13:57 ET — Regular session in progress. Shares of AbbVie Inc picked up 0.5% to reach $232.75 Tuesday afternoon, squeezing out gains while most of the health-care sector stayed flat.

February 17, 2026

Finance·Healthcare·Investments·News

UnitedHealth stock price slips as CEO investment report renews scrutiny

New York, February 17, 2026, 11:23 — Regular session UnitedHealth Group Incorporated dropped 0.8%, trading at $290.89 as of 11:23 a.m. ET Tuesday. The move came after a Wall Street Journal report revealed CEO Stephen Hemsley had poured tens of millions into healthcare startups via his own Cloverfields Capital. Some of these firms either compete with or count UnitedHealth as a client. According to UnitedHealth’s statement to the Journal, Hemsley “continues to comply fully with UnitedHealth Group’s conflict of interest and trading policies.” The company also told the paper Hemsley has shifted his personal healthcare investments into a trust overseen by independent trustees.

February 17, 2026

Finance·Healthcare·News·Stock Market

Johnson & Johnson stock slips after FDA nod for Rybrevant Faspro; traders eye next catalyst

New York, Feb 17, 2026, 11:16 EST — Regular session. Johnson & Johnson slipped around 0.2% to $242.92 late Tuesday morning. Shares changed hands between $242.20 and $244.56 earlier in the session.

February 17, 2026

Finance·Healthcare·News·Stocks

UnitedHealth stock pauses for a holiday — new Medicare Advantage numbers set up the next move

New York, Feb 16, 2026, 16:59 — Market closed UnitedHealth Group ended Friday up 3.1% at $293.19, trading as high as $294 during the session and dropping to a low of $283.41. Roughly 10.3 million shares changed hands before the close. With markets shut Monday for Presidents Day, the next move waits.

February 16, 2026

Finance·Healthcare·News·Stock Market

Eli Lilly stock price set for Tuesday test after Retevmo lung cancer trial win

New York, Feb 16, 2026, 17:16 EST — Market closed. Eli Lilly and Company is back in focus as U.S. markets reopen Tuesday, with investors digesting the latest cancer-trial news following the Washington’s Birthday holiday. The stock closed Friday at $1,040, gaining about 0.2%. During the session, shares moved between approximately $1,033 and $1,064.

February 16, 2026

Previous 1 2 3 4 5 6 Next